Monitoring of treatment with L-asparaginase in children with acute lymphoblastic leukaemia, with a focus on silent inactivation and its influence on the treatment outcome.

MLA

Czogala, Malgorzata, et al. “Monitoring of Treatment with L-Asparaginase in Children with Acute Lymphoblastic Leukaemia, with a Focus on Silent Inactivation and Its Influence on the Treatment Outcome.” Contemporary Oncology / Współczesna Onkologia, vol. 26, no. 4, Oct. 2022, pp. 282–52. EBSCOhost, https://doi.org/10.5114/wo.2023.124972.

APA

Czogala, M., Rogatko, I., Pawińska-Wąsikowska, K., Czogała, W., Bal, W., Ciebiera, M., Chaber, R., Chodała-Grzywacz, A., Karolczyk, G., Sztefko, K., Balwierz, W., & Skoczeń, S. (2022). Monitoring of treatment with L-asparaginase in children with acute lymphoblastic leukaemia, with a focus on silent inactivation and its influence on the treatment outcome. Contemporary Oncology / Współczesna Onkologia, 26(4), 282–52. https://doi.org/10.5114/wo.2023.124972

Chicago

Czogala, Malgorzata, Iwona Rogatko, Katarzyna Pawińska-Wąsikowska, Wojciech Czogała, Wioletta Bal, Małgorzata Ciebiera, Radosław Chaber, et al. 2022. “Monitoring of Treatment with L-Asparaginase in Children with Acute Lymphoblastic Leukaemia, with a Focus on Silent Inactivation and Its Influence on the Treatment Outcome.” Contemporary Oncology / Współczesna Onkologia 26 (4): 282–52. doi:10.5114/wo.2023.124972.